Abridge Goes Beyond Documentation: 4 Updates

Clinical AI startup Abridge held a New York City event to signal it’s done being thought of as just an AI scribe. The company announced a Nvidia foundation model partnership, an Eli Lilly investment, new capabilities for its platform, and the intent to help mediate the relationship between payers and providers. The post Abridge Goes…

Read More

A Simple Act of Kindness Creates a Lasting Impact at Texas Children’s Hospital

Sometimes the most meaningful moments of care happen when someone simply takes the time to be present.  While making her regular rounds at Texas Children’s Hospital, The Woodlands, Environmental Services (EVS) Houskeeper Maruja Caballero, heard a young patient crying. When she arrived at his room to collect the trash, she stopped in her tracks and moved into action to help.  …

Read More

Novartis RNA Med From $12B Deal Keeps Building Case to Become First Therapy for Rare Muscle Disease

Novartis said its RNA therapy del-brax met goals of a Phase 1/2 study in facioscapulohumeral muscular dystrophy (FSHD), an inherited muscle disorder that currently has no FDA-approved medicines. Del-brax is one of three RNA therapies from Novartis’s $12 billion acquisition of Avidity Biosciences. The post Novartis RNA Med From $12B Deal Keeps Building Case to…

Read More

The Identity Gap Undermining Value-Based Care

[Sponsored] A webinar sponsored by Verato and scheduled for June 17 from 1 pm to 2 pm ET will explore how a unified identity strategy, spanning patients, providers, and emerging solutions enabling accurate attribution, strengthens interoperability, and ultimately drives VBC success. Register today! The post The Identity Gap Undermining Value-Based Care appeared first on MedCity News.

Read More